PODCAST
When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study
August 21, 2026·10:15·Episode 107
Quick Summary
This episode covers a qualitative study on how fragmented care systems fail women experiencing suicidality during menopause, a promising new blood marker for detecting bone thinning early, and the launch of one of the most detailed long-term menopause studies ever designed. Friday format — research grounded, lighter in places, and worth your weekend thinking.
When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study
0:000:00
Key Takeaways
- ✦A 2026 qualitative study found that clinicians and caregivers consistently identified fragmented, siloed care as a key failure point when menopausal women reached a mental health crisis — menopause and mental health services often don't talk to each other.
- ✦Suicidality during perimenopause and menopause is real and documented, but it remains dramatically undertreated and under-recognized in primary care.
- ✦Xylosyltransferase-I (XT-I) is a blood enzyme that may signal bone thinning earlier than current standard tests — still early-stage research, but worth watching.
- ✦The KiSO-DP cohort study will track women through the full menopausal transition using biological, psychological, and lifestyle data collected from the same participants over time — the kind of within-person design that produces much more reliable answers than snapshot studies.
- ✦Research on menopause is getting more ambitious and more rigorous — and the questions being asked are finally catching up to what women have been reporting for decades.
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.